Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA under pressure for BPA safety

This article was originally published in The Tan Sheet

Executive Summary

Following a Sept. 17 study in the Journal of American Medical Association that finds higher concentrations of Bisphenol A in human urine is associated with cardiovascular disease, diabetes and liver-enzyme abnormalities, Reps. Rosa DeLauro, D-Conn., and John Dingell, D-Mich., criticize FDA's determination that BPA in food lining containers is safe. DeLauro says in a Sept. 16 release that FDA's stance on BPA's safety is "perplexing and dangerous." Likewise, Dingell urged the agency to "take careful notice of this new research during its Science Board meeting on Bisphenol A" Sept. 16, according to a same-day release. The most recent JAMA study does not conclusively link BPA in food containers as a cause of the associated diseases

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel